{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:21:39Z","timestamp":1783056099416,"version":"3.54.6"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Research Fund of Nanfang Hospital, Southern Medical University","award":["2024B037"],"award-info":[{"award-number":["2024B037"]}]},{"name":"Research Fund of Nanfang Hospital, Southern Medical University","award":["2021B03"],"award-info":[{"award-number":["2021B03"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0529005"],"award-info":[{"award-number":["2024ZD0529005"]}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2025A1515010067"],"award-info":[{"award-number":["2025A1515010067"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinical Research Project of Nanfang Hospital, Southern Medical University","award":["2023CR015"],"award-info":[{"award-number":["2023CR015"]}]},{"name":"Special Application for Research Project on Pathogenic Microorganism Detection Technology and Infection Prevention and Control","award":["BH006531"],"award-info":[{"award-number":["BH006531"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2406400"],"award-info":[{"award-number":["2022YFC2406400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"higher education teaching reform project","award":["24NJ-YB08"],"award-info":[{"award-number":["24NJ-YB08"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Salmonella enterica<\/jats:italic>\n                      serotype Kentucky (\n                      <jats:italic>S<\/jats:italic>\n                      . Kentucky) is a globally distributed food-borne zoonotic pathogen. It is increasingly associated with multi-drug resistance (MDR), notably to ciprofloxacin, a trend largely attributed to antibiotic overuse in humans and livestock.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      An acute erythroid leukemia (AML-M6) man was found to be infected with carbapenem-resistant (CR)\n                      <jats:italic>Salmonella enterica<\/jats:italic>\n                      after chemotherapy.\n                      <jats:italic>Salmonella<\/jats:italic>\n                      serum agglutination test showed that the strain belonged to\n                      <jats:italic>S<\/jats:italic>\n                      . Kentucky. Antimicrobial susceptibility test showed that this strain is an MDR strain (resistant to carbapenems, ciprofloxacin, third-generation cephalosporins). Carbapenemase production was assessed via a colloidal gold immunochromatography assay and indicated expression of an NDM enzyme. Whole genome sequencing (WGS) revealed that this strain carried blaNDM-5, blaCTXM-55, and blaTEM-1 genes. Based on the identification of an NDM carbapenemase, in vitro synergy testing was performed, which demonstrated a synergistic effect between aztreonam and ceftazidime-avibactam. The patient was successfully treated with this combination regimen and recovered.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This report describes an unusual infection caused by an NDM-5-producing\n                      <jats:italic>S<\/jats:italic>\n                      . Kentucky in an immunocompromised host. It underscores the necessity of employing combined phenotypic, immunologic, and molecular diagnostics to rapidly elucidate resistance mechanisms in such complex cases. Guided by this comprehensive analysis, the combination of aztreonam and ceftazidime-avibactam proved to be an effective, mechanism-based therapeutic strategy, highlighting its value in managing challenging infections in patients with hematological malignancies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13519-9","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T09:44:10Z","timestamp":1781084650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Successful treatment of an NDM-5-producing, carbapenem-resistant Salmonella Kentucky ST198 infection with aztreonam and ceftazidime-avibactam in a patient with acute erythroid leukemia: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Yingcheng","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengrui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"13519_CR1","doi-asserted-by":"publisher","unstructured":"Zhang J, Ebosa O, Diarra M, Nadon C, McAllister T, Sparling R, Narvaez-Bravo C. Genomic Drivers of Biofilm Formation in Salmonella Enteritidis and S. Kentucky from Poultry Production. Microorganisms. 2025 Oct 29;13(11):2473. https:\/\/doi.org\/10.3390\/microorganisms13112473.","DOI":"10.3390\/microorganisms13112473"},{"key":"13519_CR2","doi-asserted-by":"publisher","unstructured":"EFSA ECDC. The european union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2020\/2021. EFSA J. 2023 Mar 6;21(3):e07867. https:\/\/doi.org\/10.2903\/j.efsa.2023.7867.","DOI":"10.2903\/j.efsa.2023.7867"},{"key":"13519_CR3","doi-asserted-by":"publisher","unstructured":"Zhang X, Huang X, Li X, Wang Z, Jiang Y, Jiao X, Li Q, Wang J, Zhong F. Emergence of ciprofloxacin- and tigecycline-resistant extended-spectrum \u03b2-lactamase (ESBL)-producing Salmonella enterica serovar Kentucky ST198 from horse, China. J Glob Antimicrob Re. 2025 Sep:44:207\u2013210. https:\/\/doi.org\/10.1016\/j.jgar.2025.06.020.","DOI":"10.1016\/j.jgar.2025.06.020"},{"key":"13519_CR4","doi-asserted-by":"publisher","unstructured":"Oh B, Boyle F, Pavlakis N, Clarke S, Guminski A, Eade T, Lamoury G, Carroll S, Morgia M, Kneebone A et al. Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical Review. Front Oncol. 2021 Sep 16:11706331. https:\/\/doi.org\/10.3389\/fonc.2021.706331.","DOI":"10.3389\/fonc.2021.706331"},{"key":"13519_CR5","doi-asserted-by":"publisher","unstructured":"Wang Y, Xu X, Jia S, Qu M, Pei Y, Qiu S, Zhang J, Liu Y, Ma S, Lyu N et al. A global atlas and drivers of antimicrobial resistance in Salmonella during 1900\u20132023. Nat Commun. 2025 May 17;16(1):4611. https:\/\/doi.org\/10.1038\/s41467-025-59758-3.","DOI":"10.1038\/s41467-025-59758-3"},{"issue":"1","key":"13519_CR6","doi-asserted-by":"publisher","first-page":"2576588","DOI":"10.1080\/22221751.2025.2576588","volume":"14","author":"K Chen","year":"2025","unstructured":"Chen K, Peng J, Peng Z, Xiao R, Wang N, Deng Y, Wu C, Zheng Z, Guan J, Tang Y, et al. Global genomic survey of Salmonella Kentucky: discovery of a chromosomeborne blaNDM-5 and the emergence of ST314, an MDR clone mediated by the IncR plasmid. Emerg Microbes Infect. 2025 Dec;14(1):2576588. https:\/\/doi.org\/10.1080\/22221751.2025.2576588.","journal-title":"Emerg Microbes &amp;Infections"},{"key":"13519_CR7","doi-asserted-by":"publisher","unstructured":"Luo Y, Sheikh TMM, Li X, Yuan Y, Yao F, Wang M, Guo X, Wu J, Shafiq M, Xie Q, et al. Exploring the dynamics of gut microbiota, antibiotic resistance, and chemotherapy impact in acute leukemia patients: a comprehensive metagenomic analysis. Virulence. 2024 Dec;15(1):2428843. https:\/\/doi.org\/10.1080\/21505594.2024.2428843.","DOI":"10.1080\/21505594.2024.2428843"},{"key":"13519_CR8","doi-asserted-by":"publisher","unstructured":"Zhang F, Li T, Bai Y, Liu J, Qin J, Wang A, Zhu Y, Zhang M, Ma Z, Zhou X, et al. Treatment strategies with combined agency against severe viral pneumonia in patients with advanced cancer. J Transl Intern Med. 2024 Jul 27;12(3):317\u201320. https:\/\/doi.org\/10.2478\/jtim-2024-0007.","DOI":"10.2478\/jtim-2024-0007"},{"key":"13519_CR9","doi-asserted-by":"publisher","unstructured":"Guo M, Shang S, Li M, Cai G, Li P, Chen X, Li Q. Understanding autoimmune response after SARS-CoV-2 infection and the pathogenesis\/mechanisms of long COVID. Med Rev. 2024 May 27;4(5):367\u201383. https:\/\/doi.org\/10.1515\/mr-2024-0013.","DOI":"10.1515\/mr-2024-0013"},{"issue":"2","key":"13519_CR10","doi-asserted-by":"publisher","first-page":"111720","DOI":"10.1016\/j.isci.2024.111720","volume":"28","author":"K Zhao","year":"2025","unstructured":"Zhao K, Jin J, Liao Y, Liu A, Liu W, Wu W. IS15DIV-flanked composite transposon harboring blaNDM-5 in multidrug-resistant Salmonella Typhimurium. ISCIENCE. 2025;28(2):111720.","journal-title":"ISCIENCE"},{"key":"13519_CR11","doi-asserted-by":"publisher","unstructured":"Sati H, Carrara E, Savoldi A, Hansen P, Garlasco J, Campagnaro E, Boccia S, Castillo-Polo JA, Magrini E, Garcia-Vello P, et al. The WHO bacterial priority pathogens list 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance. Lancet Infect Dis. 2025 Sep;25(9):1033\u201343. https:\/\/doi.org\/10.1016\/S1473-30992500118-5.","DOI":"10.1016\/S1473-30992500118-5"},{"key":"13519_CR12","doi-asserted-by":"publisher","unstructured":"Miriagou V, Tzouvelekis LS, Rossiter S, Tzelepi E, Angulo FJ, Whichard JM. Imipenem resistance in a salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob Agents Chemother. 2003 Apr;47(4):1297\u2013300. https:\/\/doi.org\/10.1128\/AAC.47.4.1297-1300.2003.","DOI":"10.1128\/AAC.47.4.1297-1300.2003"},{"key":"13519_CR13","doi-asserted-by":"publisher","unstructured":"Sarkar A, Pazhani GP, Chowdhury G, Ghosh A, Ramamurthy T. Attributes of carbapenemase encoding conjugative plasmid pNDM-SAL from an extensively drug-resistant Salmonella enterica Serovar Senftenberg. Front Microbiol. 2015 Sep 15:6969. https:\/\/doi.org\/10.3389\/fmicb.2015.00969.","DOI":"10.3389\/fmicb.2015.00969"},{"key":"13519_CR14","doi-asserted-by":"publisher","first-page":"35527","DOI":"10.1038\/srep35527","volume":"21","author":"S Abraham","year":"2016","unstructured":"Abraham S, Dea MO, Trott DJ, Abraham RJ, Hughes D, Pang S, McKew G, Cheong EYL, Merlino J, Saputra S, et al. Isolation and plasmid characterization of carbapenemase (IMP-4) producing Salmonella enterica Typhimurium from cats. Sci Rep. 2016 Oct;21:6:35527. https:\/\/doi.org\/10.1038\/srep35527.","journal-title":"Sci Rep"},{"issue":"2","key":"13519_CR15","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/jac\/dks393","volume":"68","author":"J Fischer","year":"2013","unstructured":"Fischer J, Rodr\u00edguez I, Schmoger S, Friese A, Roesler U, Helmuth R, Guerra B. Salmonella enterica subsp. enterica producing VIM-1 carbapenemase isolated from livestock farms. J Antimicrob Chemother. 2013 Feb;68(2):478\u201380. https:\/\/doi.org\/10.1093\/jac\/dks393.","journal-title":"J Antimicrob Chemother"},{"key":"13519_CR16","doi-asserted-by":"publisher","unstructured":"Jiang Y, Wang Z, Li Q, Lu M, Wu H, Mei C, Shen P, Jiao X, Wang J. Characterization of extensively drug-resistant salmonella enterica serovar kentucky sequence type 198 isolates from chicken meat products in Xuancheng, China. Microbiol Spectr. 2023 Apr 13;11(2):e0321922. https:\/\/doi.org\/10.1128\/spectrum.03219-22.","DOI":"10.1128\/spectrum.03219-22"},{"issue":"1","key":"13519_CR17","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1093\/jac\/dky342","volume":"73","author":"KL Hopkins","year":"2018","unstructured":"Hopkins KL, Meunier D, Naas T, Volland H, Woodford N. Evaluation of the NG-Test CARBA 5 multiplex immunochromatographic assay for the detection of KPC, OXA-48-like, NDM, VIM and IMP carbapenemases. J Antimicrob Chemother. 2018;73(1):3523\u20136. https:\/\/doi.org\/10.1093\/jac\/dky342.","journal-title":"J Antimicrob Chemother"},{"key":"13519_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jgar.2024.11.009","volume":"40","author":"F Huang","year":"2025","unstructured":"Huang F, Guo G, Feng L, Cai T, Huang X. Genomic insights into a clinical Salmonella Typhimurium isolate carrying plasmid-mediated blaNDM-5. J Glob Antimicrob Re. 2025;40:90\u20135.","journal-title":"J GLOB ANTIMICROB RE"},{"issue":"12","key":"13519_CR19","doi-asserted-by":"publisher","first-page":"e1424","DOI":"10.1128\/spectrum.01485-24","volume":"12","author":"Y Ke","year":"2024","unstructured":"Ke Y, Zhu Z, Lu W, Liu W, Ye L, Jia C, Yue M. Emergingbla NDM -positiveSalmonella entericain Chinese pediatric infections. Microbiol Spectr. 2024;12(12):e1424\u201385.","journal-title":"MICROBIOL SPECTR"},{"issue":"6","key":"13519_CR20","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ijantimicag.2019.08.025","volume":"54","author":"L Onorato","year":"2019","unstructured":"Onorato L, Di Caprio G, Signoriello S, Coppola N. Efficacy of ceftazidime\/avibactam in monotherapy or combination therapy against carbapenem-resistant Gram-negative bacteria: A meta-analysis. Int J Antimicrob Ag. 2019;54(6):735\u201340.","journal-title":"INT J ANTIMICROB AG"},{"issue":"11","key":"13519_CR21","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1093\/cid\/ciaa586","volume":"72","author":"M Falcone","year":"2020","unstructured":"Falcone M, Daikos GL, Tiseo G, Bassoulis D, Giordano C, Galfo V, Leonildi A, Tagliaferri E, Barnini S, Sani S, et al. Efficacy of Ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by metallo-\u03b2-lactamase-producing enterobacterales. Clin Infect Dis. 2020;72(11):1871\u20138.","journal-title":"CLIN INFECT DIS"},{"key":"13519_CR22","doi-asserted-by":"publisher","first-page":"104645","DOI":"10.1016\/j.meegid.2020.104645","volume":"87","author":"CJ Park","year":"2021","unstructured":"Park CJ, Li J, Zhang X, Gao F, Benton CS, Andam CP. Diverse lineages of multidrug resistant clinical Salmonella enterica and a cryptic outbreak in New Hampshire, USA revealed from a year-long genomic surveillance. Infect Genet Evol. Jan; 2021;87:104645. https:\/\/doi.org\/10.1016\/j.meegid.2020.104645.","journal-title":"Infect Genet Evol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13519-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13519-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13519-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:07:01Z","timestamp":1783055221000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13519-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13519"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13519-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"17 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1224"}}